Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENIOLISIB vs LEUCOVORIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENIOLISIB vs LEUCOVORIN: Safety Overview

Metric LENIOLISIB LEUCOVORIN
Total FAERS Reports 570 24,977
Deaths Reported 6 3,932
Death Rate 1.1% 15.7%
Hospitalizations 54 10,039
Average Patient Age 19.4 yrs 58.5 yrs
% Female Patients 27.3% 43.5%
FDA Approval Date Mar 24, 2023 Approved Prior to Jan 1, 1982
Manufacturer Pharming Healthcare Inc. Leading Pharma, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued